DalsnaFinance › IPOs › Krystal Biotech Inc › IPO
Krystal Biotech, Inc. completed its initial public offering on NASDAQ on September 20, 2017, pricing at $10.00 a share.
| Ticker | KRYS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 20, 2017 |
| Offering price | $10.00 |
| Shares offered | 3,960,000 |
| Total raised | $40M |
Krystal Biotech, Inc. sold 3,960,000 shares at $10.00 each on NASDAQ. Multiplied out, that is $39.6 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $40 million total recorded for the deal.
Krystal Biotech, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Krystal Biotech, Inc.. This page is general information, not investment advice.